| The iron chelator deferasirox protects mice from mucormycosis through iron starvation AS Ibrahim, T Gebermariam, Y Fu, L Lin, MI Husseiny, SW French, ... The Journal of clinical investigation 117 (9), 2649-2657, 2007 | 358 | 2007 |
| Posaconazole mono-or combination therapy for treatment of murine zygomycosis AS Ibrahim, T Gebremariam, JA Schwartz, JE Edwards Jr, B Spellberg Antimicrobial Agents and Chemotherapy 53 (2), 772-775, 2009 | 123 | 2009 |
| Acute liver failure P Rajaram, R Subramanian Seminars in Respiratory and Critical Care Medicine 39 (05), 513-522, 2018 | 82* | 2018 |
| Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model JA Olson, JP Adler-Moore, J Schwartz, GM Jensen, RT Proffitt Antimicrobial agents and chemotherapy 50 (6), 2122-2131, 2006 | 77 | 2006 |
| Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products JA Olson, JP Adler-Moore, GM Jensen, J Schwartz, MC Dignani, ... Antimicrobial agents and chemotherapy 52 (1), 259-268, 2008 | 74 | 2008 |
| Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B PJ Smith, JA Olson, D Constable, J Schwartz, RT Proffitt, JP Adler-Moore Journal of antimicrobial chemotherapy 59 (5), 941-951, 2007 | 67 | 2007 |
| Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients L O'Connor, J Livermore, AD Sharp, J Goodwin, L Gregson, SJ Howard, ... The Journal of infectious diseases 208 (2), 351-361, 2013 | 58 | 2013 |
| Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease WW Hope, L McEntee, J Livermore, S Whalley, A Johnson, N Farrington, ... MBio 8 (4), 10.1128/mbio. 01157-17, 2017 | 54 | 2017 |
| Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus CE Negri, A Johnson, L McEntee, H Box, S Whalley, JA Schwartz, ... The Journal of infectious diseases 217 (7), 1118-1127, 2018 | 47 | 2018 |
| Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice JA Olson, JA Schwartz, D Hahka, N Nguyen, T Bunch, GM Jensen, ... Sabouraudia 53 (2), 107-118, 2014 | 44 | 2014 |
| Differential gene expression induced by exposure of captive mink to fuel oil: a model for the sea otter L Bowen, F Riva, C Mohr, B Aldridge, J Schwartz, AK Miles, JL Stott EcoHealth 4, 298-309, 2007 | 41 | 2007 |
| Chronic fuel oil toxicity in American mink (Mustela vison): systemic and hematological effects of ingestion of a low-concentration of bunker C fuel oil JA Schwartz, BM Aldridge, BL Lasley, PW Snyder, JL Stott, FC Mohr Toxicology and Applied Pharmacology 200 (2), 146-158, 2004 | 40 | 2004 |
| Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity KV Clemons, JA Schwartz, DA Stevens Antimicrobial agents and chemotherapy 56 (8), 4439-4449, 2012 | 39 | 2012 |
| Experimental models of short courses of liposomal amphotericin B for induction therapy for cryptococcal meningitis J Lestner, L McEntee, A Johnson, J Livermore, S Whalley, J Schwartz, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00090-17, 2017 | 36 | 2017 |
| Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days J Livermore, SJ Howard, AD Sharp, J Goodwin, L Gregson, T Felton, ... MBio 5 (1), 10.1128/mbio. 00725-13, 2014 | 31 | 2014 |
| Comparison of antifungal treatments for murine fusariosis B Spellberg, J Schwartz, Y Fu, V Avanesian, J Adler-Moore, ... Journal of Antimicrobial Chemotherapy 58 (5), 973-979, 2006 | 29 | 2006 |
| Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis KV Clemons, JA Schwartz, DA Stevens Medical Mycology 49 (8), 834-847, 2011 | 28 | 2011 |
| Immunophenotypic and functional effects of bunker C fuel oil on the immune system of American mink (Mustela vison) JA Schwartz, BM Aldridge, JL Stott, FC Mohr Veterinary immunology and immunopathology 101 (3-4), 179-190, 2004 | 26 | 2004 |
| Calcinosis circumscripta of the thoracic wall in a German shepherd dog EB Davidson, KS Schulz, ER Wisner, JA Schwartz Journal of the American Animal Hospital Association 34 (2), 153-156, 1998 | 20 | 1998 |
| Safety and efficacy of activated transfected killer cells for neutropenic fungal infections L Lin, AS Ibrahim, B Baquir, Y Fu, D Applebaum, J Schwartz, A Wang, ... The Journal of infectious diseases 201 (11), 1708-1717, 2010 | 17 | 2010 |
